Immunitybio is trading 6% up now at $8.38 as biotechnology stocks and broader markets rally on improved risk appetite following the Federal Reserve’s September 16 rate decision.
- Biotech sector is up 2.55%, supporting the move.
- Major indexes are also higher, with the Nasdaq up 1.49%.
- No new company-specific announcement dated September 17 was identified.